303 related articles for article (PubMed ID: 16234566)
1. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
[TBL] [Abstract][Full Text] [Related]
2. Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.
Alibhai SM; Leach M; Warde P
Cancer; 2009 Jan; 115(2):293-302. PubMed ID: 19025976
[TBL] [Abstract][Full Text] [Related]
3. Impact of hospital and surgeon volume on mortality and complications after prostatectomy.
Alibhai SM; Leach M; Tomlinson G
J Urol; 2008 Jul; 180(1):155-62; discussion 162-3. PubMed ID: 18485382
[TBL] [Abstract][Full Text] [Related]
4. Patterns of care for radical prostatectomy in the United States from 2003 to 2005.
Hu JC; Hevelone ND; Ferreira MD; Lipsitz SR; Choueiri TK; Sanda MG; Earle CC
J Urol; 2008 Nov; 180(5):1969-74. PubMed ID: 18801512
[TBL] [Abstract][Full Text] [Related]
5. Rethinking 30-day mortality risk after radical prostatectomy.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Naglie G
Urology; 2006 Nov; 68(5):1057-60. PubMed ID: 17113897
[TBL] [Abstract][Full Text] [Related]
6. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
[TBL] [Abstract][Full Text] [Related]
7. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
8. Re: 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Russo A; Autelitano M; Bisanti L
J Natl Cancer Inst; 2006 Mar; 98(6):421; author reply 421-2. PubMed ID: 16537836
[No Abstract] [Full Text] [Related]
9. Laparoscopic radical prostatectomy is feasible and effective in 'fit' senior men with localized prostate cancer.
Sanchez-Salas R; Prapotnich D; Rozet F; Mombet A; Cathala N; Barret E; Galiano M; Cathelineau X; Vallancien G
BJU Int; 2010 Nov; 106(10):1530-6. PubMed ID: 20230390
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
11. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
Walz J; Montorsi F; Jeldres C; Suardi N; Shariat SF; Perrotte P; Arjane P; Graefen M; Pharand D; Karakiewicz PI
BJU Int; 2008 Apr; 101(7):826-32. PubMed ID: 18321316
[TBL] [Abstract][Full Text] [Related]
12. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database.
Fairey A; Chetner M; Metcalfe J; Moore R; Todd G; Rourke K; Voaklander D; Estey E
J Urol; 2008 Jul; 180(1):128-34; discussion 134. PubMed ID: 18485375
[TBL] [Abstract][Full Text] [Related]
13. Examining the location and cause of death within 30 days of radical prostatectomy.
Alibhai SM; Leach M; Tomlinson G
BJU Int; 2005 Mar; 95(4):541-4. PubMed ID: 15705076
[TBL] [Abstract][Full Text] [Related]
14. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
[TBL] [Abstract][Full Text] [Related]
15. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
[TBL] [Abstract][Full Text] [Related]
16. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.
Houterman S; Janssen-Heijnen ML; Verheij CD; Kil PJ; van den Berg HA; Coebergh JW
Prostate Cancer Prostatic Dis; 2006; 9(2):179-84. PubMed ID: 16534509
[TBL] [Abstract][Full Text] [Related]
17. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
[TBL] [Abstract][Full Text] [Related]
18. Is there age bias in the treatment of localized prostate carcinoma?
Alibhai SM; Krahn MD; Cohen MM; Fleshner NE; Tomlinson GA; Naglie G
Cancer; 2004 Jan; 100(1):72-81. PubMed ID: 14692026
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
[TBL] [Abstract][Full Text] [Related]
20. Is there an optimal comorbidity index for prostate cancer?
Alibhai SM; Leach M; Tomlinson GA; Krahn MD; Fleshner NE; Naglie G
Cancer; 2008 Mar; 112(5):1043-50. PubMed ID: 18286512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
